Terkko Navigator / Lancet Respiratory Medicine

Lung function testing in the COVID-19 endemic

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Testing for COVID-19

Targeting MET amplification in EGFR-mutant non-small-cell lung cancer

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission

Increased cardiovascular mortality in African Americans with COVID-19

Tobacco smoking and COVID-19 infection

Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2

Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Challenges in the interpretation and application of typical imaging features of COVID-19

Correction to Lancet Respir Med 2020; 8: e21

Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation

COVID-19 and the impact of social determinants of health

Walking the line between benefit and harm from tracheostomy in COVID-19

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Tracheostomy in the COVID-19 era: global and multidisciplinary guidance

Pulmonary fibrosis secondary to COVID-19: a call to arms?

Management of acute kidney injury in patients with COVID-19

SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors

Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities

Assessment of SARS-CoV-2 replication in the context of other respiratory viruses

Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures

Airway management for COVID-19: a move towards universal videolaryngoscope?

Immunomodulation in COVID-19

A 5-point strategy for improved connection with relatives of critically ill patients with COVID-19

South America prepares for the impact of COVID-19

Keeping COVID-19 at bay in Africa

COVID-19 in Nigeria: a disease of hunger

Immunotherapies for COVID-19: lessons learned from sepsis

Considerations for ventilator triage during the COVID-19 pandemic

COVID-19 cytokine storm: the interplay between inflammation and coagulation

Reflecting on World Asthma Day in the era of COVID-19

Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic

High versus low PEEP in non-recruitable collapsed lung tissue: possible implications for patients with COVID-19

Use of non-invasive ventilation for patients with COVID-19: a cause for concern?

Kidney transplant programmes during the COVID-19 pandemic

Blood transfusion strategies and ECMO during the COVID-19 pandemic

Blood transfusion strategies and ECMO during the COVID-19 pandemic – Authors' reply

Impact of COVID-19 on people with cystic fibrosis

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

COVID-19: Respiratory support outside the intensive care unit

Challenges in lung cancer therapy during the COVID-19 pandemic

POCUS in COVID-19: pearls and pitfalls

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Understanding pathways to death in patients with COVID-19

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

Monitoring the COVID-19 epidemic in the context of widespread local transmission

β-blockade in sepsis: regulation of persisting sepsis-related tachycardia